Starting on:
Jun 30, 2021
Ending on:
Jun 30, 2021
Moderator(s):
Venue:
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
Jun 30, 2021
Ending on:
Jun 30, 2021
Moderator(s):
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
JOURNAL CLUB - 30/06/2021
Starting on:
Jun 30, 2021 8:00 AM
Jun 30, 2021 8:00 AM
Ending on:
Jun 30, 2021 9:30 AM
Jun 30, 2021 9:30 AM
Venue:
THE KAREN HOSPITAL
THE KAREN HOSPITAL
Description
A-HeFT (African-American Heart Failure Trial), which involved African Americans with a low ejection fraction and a dilated left ventricle.
Objectives
- The African-American Heart Failure Trial (A-HeFT) is double-blind, placebo-controlled, and includes African American patients with stable New York Heart Association Class III-IV HF on standard therapy.
- The goal of the African-American Heart Failure Trial (A-HeFT) was to evaluate treatment with a fixed dose of isosorbide dinitrate plus hydralazine compared with placebo among black patients with advanced heart failure.
- The primary efficacy endpoint is a composite score including quality of life, death, and hospitalization for HF.
Presenters
-
Dr.
SHAMMAR MUYAKA
Medical Officer
THE KAREN HOSPITAL